Abstract
The applications of artificial intelligence and nanotechnology have been
increasing in various sectors of society, particularly the pharmaceutical industry. The
amalgamation of these two domains is allowing for improved patient data acquisition
and the design of nanomaterials for precision cancer medicine. The crosstalk between
the tools and techniques utilized in AI could improve the design of nanomedicine by
improving material properties and the selection of drug combinations. To this end, this
review discusses nanotechnology coupled with AI and its possible applications in the
future of precision cancer medicine.
Keywords: Cancer nanomedicine, Deep learning, Drug discovery, Machine learning, Robotics.
Related Journals
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Diabetes Reviews
Current Neurovascular Research
Current Respiratory Medicine Reviews
Current Pediatric Reviews
Infectious Disorders - Drug Targets
Current Stem Cell Research & Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets
Current Alzheimer Research
Current Aging Science
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents